91 related articles for article (PubMed ID: 35579119)
1. Olverembatinib inhibits SARS-CoV-2-Omicron variant-mediated cytokine release in human peripheral blood mononuclear cells.
Chan M; Holland EC; Gujral TS
EMBO Mol Med; 2022 Jun; 14(6):e15919. PubMed ID: 35579119
[TBL] [Abstract][Full Text] [Related]
2. Induction of Exaggerated Cytokine Production in Human Peripheral Blood Mononuclear Cells by a Recombinant SARS-CoV-2 Spike Glycoprotein S1 and Its Inhibition by Dexamethasone.
Olajide OA; Iwuanyanwu VU; Lepiarz-Raba I; Al-Hindawi AA
Inflammation; 2021 Oct; 44(5):1865-1877. PubMed ID: 33860869
[TBL] [Abstract][Full Text] [Related]
3. Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8
Redd AD; Nardin A; Kared H; Bloch EM; Abel B; Pekosz A; Laeyendecker O; Fehlings M; Quinn TC; Tobian AAR
mBio; 2022 Apr; 13(2):e0361721. PubMed ID: 35229637
[TBL] [Abstract][Full Text] [Related]
4. Computational profiling of natural compounds as promising inhibitors against the spike proteins of SARS-CoV-2 wild-type and the variants of concern, viral cell-entry process, and cytokine storm in COVID-19.
Kar P; Saleh-E-In MM; Jaishee N; Anandraj A; Kormuth E; Vellingiri B; Angione C; Rahman PKSM; Pillay S; Sen A; Naidoo D; Roy A; Choi YE
J Cell Biochem; 2022 May; 123(5):964-986. PubMed ID: 35342986
[TBL] [Abstract][Full Text] [Related]
5. Fusion-inhibition peptide broadly inhibits influenza virus and SARS-CoV-2, including Delta and Omicron variants.
Zhao H; Meng X; Peng Z; Lam H; Zhang C; Zhou X; Chan JF; Kao RYT; To KK; Yuen KY
Emerg Microbes Infect; 2022 Dec; 11(1):926-937. PubMed ID: 35259078
[TBL] [Abstract][Full Text] [Related]
6. T-cell responses to SARS-CoV-2 Omicron spike epitopes with mutations after the third booster dose of an inactivated vaccine.
Li Y; Wang X; Jin J; Ma Z; Liu Y; Zhang X; Su B
J Med Virol; 2022 Aug; 94(8):3998-4004. PubMed ID: 35474581
[TBL] [Abstract][Full Text] [Related]
7. In Silico Screening of Bioactive Compounds of Representative Seaweeds to Inhibit SARS-CoV-2 ACE2-Bound Omicron B.1.1.529 Spike Protein Trimer.
Bharathi M; Sivamaruthi BS; Kesika P; Thangaleela S; Chaiyasut C
Mar Drugs; 2022 Feb; 20(2):. PubMed ID: 35200677
[TBL] [Abstract][Full Text] [Related]
8. Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies.
Shah M; Woo HG
Front Immunol; 2021; 12():830527. PubMed ID: 35140714
[TBL] [Abstract][Full Text] [Related]
9. Cryo-EM structure of the SARS-CoV-2 Omicron spike.
Cerutti G; Guo Y; Liu L; Liu L; Zhang Z; Luo Y; Huang Y; Wang HH; Ho DD; Sheng Z; Shapiro L
Cell Rep; 2022 Mar; 38(9):110428. PubMed ID: 35172173
[TBL] [Abstract][Full Text] [Related]
10. Machine learning identifies molecular regulators and therapeutics for targeting SARS-CoV2-induced cytokine release.
Chan M; Vijay S; McNevin J; McElrath MJ; Holland EC; Gujral TS
Mol Syst Biol; 2021 Sep; 17(9):e10426. PubMed ID: 34486798
[TBL] [Abstract][Full Text] [Related]
11. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein.
Kumar S; Thambiraja TS; Karuppanan K; Subramaniam G
J Med Virol; 2022 Apr; 94(4):1641-1649. PubMed ID: 34914115
[TBL] [Abstract][Full Text] [Related]
12. Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant.
Schubert M; Bertoglio F; Steinke S; Heine PA; Ynga-Durand MA; Maass H; Sammartino JC; Cassaniti I; Zuo F; Du L; Korn J; Milošević M; Wenzel EV; Krstanović F; Polten S; Pribanić-Matešić M; Brizić I; Baldanti F; Hammarström L; Dübel S; Šustić A; Marcotte H; Strengert M; Protić A; Piralla A; Pan-Hammarström Q; Čičin-Šain L; Hust M
BMC Med; 2022 Mar; 20(1):102. PubMed ID: 35236358
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective.
Saxena SK; Kumar S; Ansari S; Paweska JT; Maurya VK; Tripathi AK; Abdel-Moneim AS
J Med Virol; 2022 Apr; 94(4):1738-1744. PubMed ID: 34905235
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 VOCs, Mutational diversity and clinical outcome: Are they modulating drug efficacy by altered binding strength?
Saifi S; Ravi V; Sharma S; Swaminathan A; Chauhan NS; Pandey R
Genomics; 2022 Sep; 114(5):110466. PubMed ID: 36041637
[TBL] [Abstract][Full Text] [Related]
15. Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination.
Dapporto F; Marchi S; Leonardi M; Piu P; Lovreglio P; Decaro N; Buonvino N; Stufano A; Lorusso E; Bombardieri E; Ruello A; Viviani S; Molesti E; Trombetta CM; Manenti A; Montomoli E
J Immunol Res; 2022; 2022():4813199. PubMed ID: 36093434
[TBL] [Abstract][Full Text] [Related]
16. Assessment of T-cell Reactivity to the SARS-CoV-2 Omicron Variant by Immunized Individuals.
De Marco L; D'Orso S; Pirronello M; Verdiani A; Termine A; Fabrizio C; Capone A; Sabatini A; Guerrera G; Placido R; Sambucci M; Angelini DF; Giannessi F; Picozza M; Caltagirone C; Salvia A; Volpe E; Balice MP; Rossini A; Rötzschke O; Giardina E; Battistini L; Borsellino G
JAMA Netw Open; 2022 Apr; 5(4):e2210871. PubMed ID: 35452102
[TBL] [Abstract][Full Text] [Related]
17. Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2.
Hu B; Chan JF; Liu H; Liu Y; Chai Y; Shi J; Shuai H; Hou Y; Huang X; Yuen TT; Yoon C; Zhu T; Zhang J; Li W; Zhang AJ; Zhou J; Yuan S; Zhang BZ; Yuen KY; Chu H
Emerg Microbes Infect; 2022 Dec; 11(1):2275-2287. PubMed ID: 36039901
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy and in vitro neutralization capacity of monoclonal antibodies for severe acute respiratory syndrome coronavirus 2 delta and omicron variants.
Brehm TT; Pfefferle S; von Possel R; Karolyi M; Zoufaly A; Wichmann D; Kobbe R; Emmerich P; Nörz D; Aepfelbacher M; Schulze Zur Wiesch J; Addo MM; Schmiedel S; Lütgehetmann M
J Med Virol; 2022 Oct; 94(10):5038-5043. PubMed ID: 35662058
[TBL] [Abstract][Full Text] [Related]
19. Expansion of L452R-Positive SARS-CoV-2 Omicron Variant, Northern Lombardy, Italy.
Novazzi F; Baj A; Genoni A; Focosi D; Maggi F
Emerg Infect Dis; 2022 Jun; 28(6):1301-1302. PubMed ID: 35416767
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 Evolution: On the Sudden Appearance of the Omicron Variant.
Berkhout B; Herrera-Carrillo E
J Virol; 2022 Apr; 96(7):e0009022. PubMed ID: 35293771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
